Skip to content

Anxiety: all studies

Page 433 of 773: studies 4,321 to 4,330 of 7,721, newest first. Back to the anxiety overview

Research

Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?

Neurobiology of Stress May 1, 2025 Alanna Kit, Kate Conway, Savannah Makarowski et al. 5 citations

There is growing interest in exploring the therapeutic potential and mechanisms of action of psilocybin on stress-related neuropsychiatric disorders, including depression, generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), addiction, and disordered eating. Despite promising progressions in preclinical and clinical research, the...

DOI: 10.1016/j.ynstr.2025.100732 (opens in new tab) 5-HT Psilocybin Inflammation Neuropsychiatric disorders +7

The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review

Health, environment and sustainable development: interdisciplinary approach April 30, 2025 Saara Susan Sevander, Marja-Liisa Susan Rissanen

The purpose of the study was to describe the benefits and harm of using psychedelics in the treatment of patients with mental health and substance abuse disorders. The study focused on classic psychedelics, specifically psilocybin and LSD. The study was carried out as an integrative literature review and the data was sought using Medic, Cinahl, PubMed MEDLINE and PsycINFO databases. A total of...

Trauma Center Trauma Sensitive Yoga Intervention (TCTSY). Improving Conditions for Incarcerated Women in Latin America.

Medicine, science, and the law April 30, 2025 Paola Solano-Durán, Luisa Pérez Escobedo, Isabel María Benjumeda Wynhoven

Female prisoners in Latin America experience significantly higher rates of mental health issues compared to their male counterparts. The most prevalent include anxiety and stress, which stem from feelings of insecurity, perceived failure, long periods of detention, and the inability to care for their children. Furthermore, over 50% of female prisoners have been exposed to traumatic events,...

DOI: 10.1177/00258024251329237 (opens in new tab) Full text (opens in new tab) Incarcerated women Body awareness Interoceptive awareness Trauma-informed-care +4

New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

Pharmaceuticals April 30, 2025 Paola Bozzatello, Roberta Novelli, Rebecca Schisano et al. 6 citations

Psychiatric disorders are a major cause of illness in the world. Unfortunately, many patients are resistant to treatment and present serious complications. Schizophrenia is refractory to treatment in about one-third of patients. Antidepressants are effective in about half of patients. Suicidal ideation is an increasing issue in patients with mixed features in bipolar disorder (BD). Therefore,...

DOI: 10.3390/ph18050665 (opens in new tab) Full text (opens in new tab) Anxiety disorders Bipolar disorder Efficacy Major depression +9

Adolescent Psychedelic Use and Mental Health Is Associated with User Personality: A Representative National Study on Drug Use

International Journal of Mental Health and Addiction April 29, 2025 David Sjöström, Emma Claesdotter-Knutsson, Isabella Gripe et al.

It is still unknown how current trends in psychedelic use among adolescents are related to mental health. This study reports on the prevalence of psychedelic use in a Swedish representative nationwide drug survey and its association with mental health outcomes and user personality. A cross-sectional study using data from the latest 2024 Swedish Council for Information on Alcohol and Other Drugs...

Evaluation of Antidepressant and Anxiolytic Activity on Medical Representative by Using Insight Meditation

International Journal of Innovative Science and Research Technology April 29, 2025 Shreyas. Y. Bobade, V. V. Paithankar, J. V. Vyas

The pharmaceutical industry in India is undergoing significant expansion, with Medical Sales Representatives (MR) playing an integral role in promoting pharmaceutical products and facilitating communication between healthcare providers and the industry. However, the demanding nature of this profession often results in elevated levels of psychological strain, including stress, anxiety, and...

Traumatic Psychedelic Experiences.

Current Topics in Behavioral Neurosciences April 29, 2025 Abigail E. Calder, Vincent J Diehl, Gregor Hasler 14 citations

Psychedelic experiences involving extreme feelings of horror, helplessness, and perceived threats can be traumatizing. Traumatic psychedelic experiences are a rare, extreme, and largely preventable form of challenging experience which can arise due to frightening psychedelic drug effects, unsafe settings, and emergence of pre-existing trauma. Some people recover quickly, but others develop...

Investigating the feasibility of an 8-week mindful breathing programme on breathlessness and self-efficacy in chronic obstructive pulmonary disease: an open-label study.

Pilot and Feasibility Studies April 29, 2025 Shirley Harris, Jennifer Jordan, Amanda Wilkinson et al. 1 citation

High prevalences of anxiety and depression have been found in those with COPD which can exacerbate physically related impacts of increased levels of disability, and reduced enjoyment of life. Of particular concern is the anxiety-breathlessness cycle and reduced self-efficacy, which both adversely affect self-management of symptoms. Recognition of the need to address these issues has led to use...

What to Expect during a Psychedelic Journey

Routledge eBooks April 28, 2025 Charmaine Husum

This chapter provides an overview of what individuals may encounter during a psychedelic journey, emphasizing that each experience is unique and influenced by factors such as mindset, environment, dosage, and the type of psychedelic used. Common experiences include vivid visual effects, enhanced sensory perception, feelings of euphoria, ego dissolution, introspection, emotional release, and...

Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review

Psychedelic Medicine April 28, 2025 Shakila Meshkat, Howell Fang, Rachel Sousa-Ho et al.

Introduction: High-dose psilocybin has shown potential in treating various psychiatric disorders, but its perceptual and cognitive effects, along with the risk of adverse events, highlight the need for alternative treatment approaches. One such approach is the use of low-dose psilocybin, which does not significantly alter cognition or perception. While low-dose psilocybin has garnered growing...